Last updated: March 5, 2026
What Is the Drug Associated with NDC 70069-0051?
NDC 70069-0051 corresponds to Jatenzo (trade name), the oral testosterone undecanoate capsule approved by the FDA in July 2019. It is used to treat male hypogonadism, a condition where the body produces insufficient testosterone.
Market Size and Demand Drivers
Current Market Landscape
- The global testosterone replacement therapy (TRT) market was valued at approximately $2.5 billion in 2022.
- The U.S. accounts for roughly 80%, or about $2 billion of that market, driven by increasing diagnosis of hypogonadism and aging male populations.
- The domestic TRT market growth rate ranges from 5% to 7% annually.
Key Demand Drivers
- Aging male demographic with decreasing endogenous testosterone levels.
- Rising awareness and diagnosis of hypogonadism.
- Patient preference for oral formulations over injections.
- Clinician shift toward hormone replacement therapy for quality of life improvements.
Competitive Landscape
- Existing oral options: Testosterone undecanoate (e.g., Jatenzo), methyltestosterone.
- Injectable therapies: Testosterone cypionate, enanthate, and proliferator formulations.
- Topically applied gels and patches.
Barriers
- Strict regulation and the need for monitoring testosterone levels.
- Limited long-term safety data.
- Competition from well-established injectable and topical products.
Pricing Overview
| Product |
Typical Price Range (per unit) |
Delivery Method |
Market Position |
| Jatenzo |
$40 - $60 (per capsule) |
Oral capsule |
Premium oral TRT |
| Testosterone injections |
$20 - $40 (per vial) |
Injection |
Cost-efficient, widespread use |
| Testosterone gel |
$50 - $70 (per month supply) |
Topical gel |
Convenient, over-the-counter options |
Current Pricing Factors
- Jatenzo’s wholesale acquisition cost (WAC) is approximately $45 – $50 per capsule.
- Insurance coverage varies, influencing patient out-of-pocket expense.
- Market penetration remains moderate due to competition and prescribing habits.
Price Projections and Market Dynamics
Factors Influencing Future Prices
- Regulatory developments: Continued FDA oversight may affect approval and labeling, impacting pricing.
- Generic entry: No generics currently; however, potential future patent expiry could lower prices.
- Market penetration: Increased acceptance and physician adoption can lead to economies of scale.
- Insurance reimbursement policies: Shifts toward more favorable coverage could reduce patient costs, potentially impacting manufacturer pricing strategies.
Short-term Projections (Next 2–3 Years)
- Price stability expected, with minor volatility around $45 – $55 per capsule.
- Market share growth could increase demand, slightly compressing margins but boosting overall sales volume.
- Competition may introduce generic versions, pressuring prices downward after patent expiration (expected around 2029–2030).
Long-term Outlook (5+ Years)
- As patents expire, prices could decrease 20%-30%, aligning with generic market entry.
- Market growth driven by increased diagnosis and expanded adult male population segments.
- Potential for combination therapies or alternative delivery forms could diversify options and affect pricing.
Summary of Key Market Projections
| Year |
Estimated Market Size (USD) |
Estimated Price Range per Capsule (USD) |
Key Factors Impacting Price |
| 2023 |
$50 million |
$45 – $55 |
Stable pricing; rising demand |
| 2025 |
$75 million |
$40 – $55 |
Increased adoption; competition begins |
| 2030 |
$120 million |
$30 – $50 (post-patent expiry) |
Generic entries; price decrease |
Key Takeaways
- NDC 70069-0051 (Jatenzo) addresses oral testosterone therapy, with a market value in the U.S. estimated at $2 billion.
- Current pricing remains stable at around $45 – $50 per capsule.
- Competition, patent exclusivity, and insurance reimbursement are primary factors influencing future prices.
- Market growth hinges on increased diagnosis, patient preference shifts toward oral delivery, and regulatory landscape stability.
- Long-term prices are likely to decline with generic market entry, but demand growth could offset revenue declines temporarily.
FAQs
1. When is patent expiration expected for Jatenzo?
Patent protections are projected to expire around 2029–2030, after which generic versions may enter the market.
2. How does Jatenzo's pricing compare to other TRT options?
Its $45–$50 per capsule pricing is higher than injectables but similar or slightly lower than topical gels, justified by its oral route.
3. What factors could lead to price increases for Jatenzo?
Supply chain shortages, increased demand, or regulatory changes restricting competition could elevate prices temporarily.
4. What is the primary driver of the TRT market growth?
An aging male population and increased diagnosis of hypogonadism are primary drivers.
5. How might insurance coverage influence future pricing of Jatenzo?
Broader reimbursement could lower out-of-pocket costs, encouraging utilization but may pressure manufacturers to adjust list prices.
References
[1] Grand View Research. (2023). Testosterone Replacement Therapy Market Size, Share & Trends.
[2] IQVIA. (2022). U.S. Prescription Drug Market Analysis.
[3] U.S. Food and Drug Administration. (2019). FDA approves Jatenzo for testosterone replacement therapy.
[4] MarketWatch. (2022). Testosterone Replacement Therapy Market Forecast.
